| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.11(B) |
| Last
Volume: |
2,501,317 |
Avg
Vol: |
1,900,163 |
| 52
Week Range: |
$65.11 - $82.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 317 |
| Guru Rank Value : 4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
26,945 |
67,902 |
123,113 |
368,767 |
| Total Sell Value |
$2,043,551 |
$5,004,391 |
$8,902,469 |
$27,563,219 |
| Total People Sold |
3 |
4 |
6 |
10 |
| Total Sell Transactions |
3 |
6 |
8 |
16 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Crawford Sally |
Director |
• • – |
2020-03-09 |
4 |
OE |
$22.35 |
$249,113 |
D/D |
11,146 |
169,943 |
|
- |
|
| Nawana Namal |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
13,713 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
158,797 |
|
- |
|
| Wendell Amy Mcbride |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
14,650 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
22,129 |
|
- |
|
| Garrett Scott T |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
27,181 |
|
- |
|
| Stamoulis Christiana |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
39,392 |
|
- |
|
| Hantson Ludwig |
Director |
• • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,217 |
5,012 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2020-02-03 |
4 |
AS |
$53.54 |
$10,407,184 |
D/D |
(194,396) |
1,697,442 |
|
-6% |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2020-02-03 |
4 |
OE |
$22.29 |
$4,814,551 |
D/D |
215,996 |
1,891,838 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2020-01-13 |
4/A |
OE |
$32.38 |
$276,266 |
D/D |
8,532 |
103,839 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2020-01-13 |
4 |
AS |
$52.78 |
$1,037,334 |
D/D |
(19,624) |
95,307 |
|
-1% |
|
| Griffin John M. |
General Counsel |
• • – |
2020-01-13 |
4 |
OE |
$32.38 |
$661,021 |
D/D |
19,624 |
106,399 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2020-01-02 |
4 |
AS |
$51.66 |
$845,687 |
D/D |
(16,348) |
28,956 |
|
2% |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2020-01-02 |
4 |
OE |
$21.45 |
$364,821 |
D/D |
16,348 |
45,304 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2019-12-04 |
4 |
S |
$52.12 |
$228,225 |
D/D |
(4,379) |
18,162 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2019-12-04 |
4 |
OE |
$21.45 |
$93,930 |
D/D |
4,379 |
22,541 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2019-12-03 |
4 |
D |
$51.69 |
$708,980 |
D/D |
(13,716) |
1,675,842 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$25,711 |
D/D |
(501) |
18,162 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$84,678 |
D/D |
(1,650) |
95,307 |
|
- |
|
| Thornal Kevin R |
Div. President, Diagnostics |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$59,121 |
D/D |
(1,152) |
17,026 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$675,320 |
D/D |
(13,159) |
1,689,558 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$22,837 |
D/D |
(445) |
28,956 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$225,757 |
D/D |
(4,399) |
59,991 |
|
- |
|
| Bebo Allison P |
SVP, Human Resources |
• • – |
2019-12-01 |
4 |
D |
$51.32 |
$55,990 |
D/D |
(1,091) |
28,389 |
|
- |
|
824 Records found
|
|
Page 12 of 33 |
|
|
1.20 (1.65%) 
